Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?

A.N. Vis, T.M. van der Sluis, H.H.M. Al-Itejawi, R.J.A. van Moorselaar, E.J.H. Meuleman

Urology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	7-15
Journal	Urologic Oncology
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.urolonc.2014.04.016
Publication status	Published - 2015

Access to Document

10.1016/j.urolonc.2014.04.016

Cite this

Vis, A. N., van der Sluis, T. M., Al-Itejawi, H. H. M., van Moorselaar, R. J. A., & Meuleman, E. J. H. (2015). Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact? Urologic Oncology, 33(1), 7-15. https://doi.org/10.1016/j.urolonc.2014.04.016

@article{271dfe2b640d437ebea44ea1884b142e,

title = "Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?",

author = "A.N. Vis and {van der Sluis}, T.M. and H.H.M. Al-Itejawi and {van Moorselaar}, R.J.A. and E.J.H. Meuleman",

year = "2015",

doi = "10.1016/j.urolonc.2014.04.016",

language = "Undefined/Unknown",

volume = "33",

pages = "7--15",

journal = "Urologic Oncology",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?

AU - Vis, A.N.

AU - van der Sluis, T.M.

AU - Al-Itejawi, H.H.M.

AU - van Moorselaar, R.J.A.

AU - Meuleman, E.J.H.

PY - 2015

Y1 - 2015

U2 - 10.1016/j.urolonc.2014.04.016

DO - 10.1016/j.urolonc.2014.04.016

M3 - Article

VL - 33

SP - 7

EP - 15

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 1

ER -